IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS), ADALIMUMAB IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (Ps) AND PREVENTS ANTERIOR UVEITIS (AU) FLARES

IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS), ADALIMUMAB IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (Ps) AND PREVENTS ANTERIOR UVEITIS (AU) FLARES

Bibliografski detalji
Glavni autori:	Wordsworth, P, Rudwaleit, M, Claudepierre, P, Loza, E, Olivieri, I, Wong, R, Oezer, U, Kary, S, Kupper, H
Format:	Conference item
Izdano:	2009

Slični predmeti

Adalimumab (HUMIRA (R)) improves inflammatory bowel disease (IBD) and psoriasis (Ps) and prevents anterior uveitis (AU) flares in patients with Ankylosing spondylitis (AS)
od: Rudwaleit, M, i dr.
Izdano: (2008)

Predictors of good clinical response (BASDAI 50 or ASAS partial remission) in 1,250 patients treated with adalimumab (humira (R)) for active ankylosing spondylitis (AS)
od: Rudwaleit, M, i dr.
Izdano: (2008)

Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis.
od: Rudwaleit, M, i dr.
Izdano: (2009)

Adalimumab is effective and well-tolerated in patients with ankylosing spondylitis (AS) in day-to-day clinical practice - Results from rhapsody
od: Wordsworth, P, i dr.
Izdano: (2008)

Efficacy of adalimumab in uveitis in patients with ankylosing spondylitis
od: Shandor Fedorovich Erdes
Izdano: (2012-03-01)

EXPERIENCE OF ADALIMUMAB TREATMENT IN PATIENT WITH JUVENILE ANKYLOSING SPONDYLITIS AND UVEITIS
od: E. V. Mitenko, i dr.
Izdano: (2012-02-01)

Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).
od: Revicki, D, i dr.
Izdano: (2008)

COURSE OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
od: A. A. Godzenko, i dr.
Izdano: (2016-09-01)

Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
od: Tatyana Valentinovna Mezenova, i dr.
Izdano: (2012-04-01)

Acute anterior uveitis with hyphema in ankylosing spondylitis
od: Hitesh R Sharma, i dr.
Izdano: (2022-01-01)

Role of secukinumab in ankylosing spondylitis with tubercular uveitis
od: Padmamalini Mahendradas, i dr.
Izdano: (2020-01-01)

Successful treatment of IgA nephropathy complicated by ankylosing spondylitis with recurrent anterior uveitis with adalimumab: one case report
od: Jia-biao Wu, i dr.
Izdano: (2024-09-01)

Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial.
od: Van der Heijde, D, i dr.
Izdano: (2005)

EXPERIENCE OF TREATMENT OF JUVENILE ANKYLOSING SPONDYLITIS WITH EYES LESION WITH ADALIMUMAB
od: E.I. Alexeeva, i dr.
Izdano: (2009-01-01)

Effect of adalimumab on quality of life in patients with active ankylosing spondylitis
od: Cao Shuangyan, Shao Zhanqin, Gu Jieruo
Izdano: (2023-06-01)

EXPERIENCE OF TREATMENT OF JUVENILE ANKYLOSING SPONDYLITIS WITH EYES LESION WITH ADALIMUMAB
od: E.I. Alexeeva, i dr.
Izdano: (2009-01-01)

Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab
od: M. Fernandes, i dr.
Izdano: (2011-11-01)

Ankylosing spondylitis (AS) in inflammatory bowel disease (IBD) is associated with possession of HLA-B27 and DR1
od: Orchard, T, i dr.
Izdano: (1997)

Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab
od: E. Filippucci, i dr.
Izdano: (2011-06-01)

Adalimumab improves physical functioning and work productivity in ankylosing spondylitis (AS) patients: Results from ATLAS.
od: van der Heijde, D, i dr.
Izdano: (2006)

Treatment with adalimumab reduces signs and symptoms and induces partial remission in patients with ankylosing spondylitis (AS): 1-year results from ATLAS.
od: van der Heijde, D, i dr.
Izdano: (2006)

Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
od: T. V. Dubinina, i dr.
Izdano: (2016-09-01)

Early Adalimumab and Anti‐Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients
od: Xiaoliang Ding, i dr.
Izdano: (2020-05-01)

LEUKOCYTOCLASTIC VASCULITIS ASSOCIATED WITH ADALIMUMAB TREATMENTIN A PATIENT WITH ANKYLOSING SPONDYLITIS
od: I A Doroshkevich, i dr.
Izdano: (2010-06-01)

Eosinophilia in a patient with ankylosing spondylitis treated with prolonged adalimumab only
od: Junhong He, i dr.
Izdano: (2022-02-01)

Reactive Arthritis Triggered by Adalimumab and Leflunomide in a Patient with Ankylosing Spondylitis
od: Liu Y, i dr.
Izdano: (2022-12-01)

Allergic bronchopulmonary aspergillosis in a patient with ankylosing spondylitis treated with adalimumab
od: Yudai Suzuki, i dr.
Izdano: (2021-08-01)

Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab
od: Dubravka Bosnić, i dr.
Izdano: (2016-12-01)

Genetics of ankylosing spondylitis.
od: Brown, M, i dr.
Izdano: (2002)

Real‐life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data
od: Sanjiv Kapoor, i dr.
Izdano: (2019-10-01)

Inefficacy or Paradoxical Effect? Uveitis in Ankylosing Spondylitis Treated with Etanercept
od: Bernd Raffeiner, i dr.
Izdano: (2014-01-01)

Secretor status and ankylosing spondylitis.
od: Pal, A, i dr.
Izdano: (1998)

Disease severity in Ankylosing Spondylitis: The influence of associated inflammatory bowel disease and psoriasis
od: Bradbury, L, i dr.
Izdano: (2008)

Adalimumab enhances health-related quality of life in patients with active ankylosing spondylitis - Results from the atlas trial
od: van der Heijde, D, i dr.
Izdano: (2006)

ANKYLOSING-SPONDYLITIS AND FUNCTIONAL ABILITY
od: Wordsworth, B, i dr.
Izdano: (1984)

Hypophosphataemia masquerading as ankylosing spondylitis
od: Wordsworth, B, i dr.
Izdano: (2008)

THE ROLE OF ANKH IN ANKYLOSING SPONDYLITIS
od: Timms, A, i dr.
Izdano: (2003)

Susceptibility to ankylosing spondylitis.
od: Carter, N, i dr.
Izdano: (2000)

The role of germline polymorphisms in the T-cell receptor in susceptibility to ankylosing spondylitis.
od: Brown, M, i dr.
Izdano: (1998)

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation
od: C McLeod, i dr.
Izdano: (2007-08-01)